Augmenting the Magnitude of HAART-Induced Immune Restoration With the Use of Cyclosporine

Trial Profile

Augmenting the Magnitude of HAART-Induced Immune Restoration With the Use of Cyclosporine

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2009

At a glance

  • Drugs Ciclosporin; Efavirenz; Lamivudine/zidovudine/abacavir
  • Indications HIV infections; HIV-1 infections
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 01 Nov 2009 Pharmacodynamic substudy results published in the European Journal of Clinical Pharmacology.
    • 13 Feb 2007 Results have been presented.
    • 13 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top